TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Decrease in pharyngeal hyperemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Concentration of Aβ in CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete resolution of subretinal fluid (SRF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean LogMAR BCVA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean central foveal thickness (CFT) decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EGF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TGF‐β1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to SARS-CoV-2 swab negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of PCIA
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total score levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Injury mechanisms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Injury treatment and prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of AF, atrial flutter, or atrial tachycardia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: decreased OPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal numerical rating scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative amount of overall opioids consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: perceived pain score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: forward recall
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: metacognition index
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Effects of dry needling and neural mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Errors in tea making across different tea types
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to make a cup of tea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of urinary ketones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Readmission/revisit rates
Endpoint domain: Mortality/survival
Primary endpoint: composite surgical failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Survival rates at 1, 3 and 5 years
Endpoint domain: Mortality/survival
Primary endpoint: Freedom from atrial arrhythmia paroxysms at 1, 3 and 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of ARI antibiotic prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of ARI visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Radiographic scoring using Bergland scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of intraneural injection
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of nerve puncture
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of needle-nerve contact
Endpoint domain: Adverse events/effects
Primary endpoint: Knowledge and attitudes toward hearing conservation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk of asthma development
Endpoint domain: Mortality/survival
Primary endpoint: weekly drinks reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak drinks reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: negative consequences reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Critically low serum vitamin D (25(OH)D) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HIV‐1 RNA level of less than 50 copies per milliliter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in C-reactive protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in serum amyloid A (SAA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in procollagen type 1 N-terminal propeptide (P1NP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: VAS for aspiration pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic JSW
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased reactivity to antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decreased reactivity to antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proficiency benchmark achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction in performance errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Kaufman Assessment Battery for Children II scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Child Behavior Checklist 1.5‐5 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Duration of invasive mechanical ventilation (IMV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma malondialdehyde (MDA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effectiveness of cabazitaxel therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of cabazitaxel therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Patient-Reported Outcomes (PROs)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dizziness Handicap Inventory improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: insulin resistance markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: hepatic health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rates to prevention program for CMD
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Incidence rate of cough
Endpoint domain: Adverse events/effects
Primary endpoint: improve mental health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduce psychological symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Risk of omphalocele formation
Endpoint domain: Mortality/survival
Primary endpoint: WOMAC dysfunction score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bone marrow lesions (BMLs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of hemidiaphragmatic paresis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: perceived health-related quality of life (HRQOL)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: suPAR concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phosphorus concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serious procedural complications
Endpoint domain: Adverse events/effects
Primary endpoint: functioning at a later point in time
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: risk of HHF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite kidney outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolites associated with dietary patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamstring concentric peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Polycystic Ovary Syndrome (PCOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: muscle strength mega-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: progression rate for SVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean time to skin‐to‐skin contact
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: engagement behaviors during tobacco cessation counseling calls
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Shelf life of pathogen-reduced RBCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lymphocyte viability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Age-related macular degeneration (AMD)
Endpoint domain: Adverse events/effects
Primary endpoint: Hypotension risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intradialytic SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall ultrafiltration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sustainment of weekly physical activity (PA) scheduled
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of AF lasting ≥30s
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients on oral anticoagulation therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain reduction on a visual analog scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Supraspinatus tendon retears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: csSCV size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: no atrial tachyarrhythmia recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of hemarthrosis episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in facial inflammatory lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: levels of suicidal ideation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of hopelessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of psychache symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants exceeding WHO recommendation of sodium intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in Food and Health related knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total work productivity impairment (TWPI)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Total activity impairment (TAI)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Psoriasis-related work presenteeism
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Thresholds measured with OtoKiosk compared to conventional audiometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain felt on VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FFI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IPK's size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean ipsilateral lung V17Gy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: shoulder toxicity, pain, fatigue, breathlessness and breast symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Transient spikes in EtCO2 (≥60 mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction of bloating and flatulence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Preoperative dental anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pao2 to Fio2 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Composite of total hospitalizations for heart failure and death from cardiovascular causes
Endpoint domain: Mortality/survival
Primary endpoint: Training volume based on TUT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-to-discontinuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Consultation and Relational Empathy scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pressure pain threshold measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved patient satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: surgical visibility score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: frequency of migraine attack
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration time of migraine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent time in glucose target (70-140 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in infraorbital hyperpigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6MWT (walking distance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of CT models
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: readmission within 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: EIMD observed by CK, LDH and GOT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: internal exercise load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety endpoint event rate
Endpoint domain: Adverse events/effects
Primary endpoint: Evaluation of proteinuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Average absolute number of myths and misconceptions believed
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: serum alanine aminotransferase (ALT) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: triacylglycerol (TAG) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolapse, bladder and bowel symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of levobupivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax of levobupivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive performance measured with MEC-35
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Serum levels of CA125 and HE4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ROMA index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improve care quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: postoperative bowel-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: genitourinary function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Surgeon-perceived procedural difficulty
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Surgeon-perceived reduction quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Michigan Hand Outcomes Questionnaire Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EQ-5D index scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Trust in officers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived effectiveness of officers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Choroidal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Macular thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: duration of nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial blood lactic acid content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum creatinine levels (Scr)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Return-to-work (RTW) rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Maintenance of employment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Duration of throat viral RNA detectability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of reported complications
Endpoint domain: Adverse events/effects
Primary endpoint: preferred method of follow-up
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Weight increase in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NK-cell function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: circulating myokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: baseline peak aerobic capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen consumption during graded exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term psychological impact
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Children's distress score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decline on DFR from baseline to 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Q‐TWiST
Endpoint domain: Mortality/survival
Primary endpoint: survival with zero downtime
Endpoint domain: Mortality/survival
Primary endpoint: Renal function improvement or stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Overall esthetic score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival margin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marginal tissue contour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: B. chinensis L. yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Water use efficiency (WUE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Japanese Orthopedic Association knee score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adverse events (grade 3 hypertension)
Endpoint domain: Adverse events/effects
Primary endpoint: Parenting burden
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Parent-child communication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Saponin content reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of gestational diabetes mellitus (GDM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Adverse perinatal composite outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dietary Diversity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Micronutrient intake estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LARC choice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LARC use within 12-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention at 6 months postnatally
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Power of discrimination (PD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polymorphic information content (PIC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observed heterozygosity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPR preference
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preferences for MV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence rate of hypothermia
Endpoint domain: Adverse events/effects